Last $0.17 USD
Change Today -0.0125 / -6.85%
Volume 145.1K
APHB On Other Exchanges
As of 8:10 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

ampliphi biosciences corp (APHB) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/17/14 - $0.74
52 Week Low
10/14/14 - $0.07
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

ampliphi biosciences corp (APHB) Related Businessweek News

No Related Businessweek News Found

ampliphi biosciences corp (APHB) Details

AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the discovery, development, and commercialization of novel bacteriophage-based therapeutics. Its lead programs consist of three product candidates, including AmpliPhage-001 for the treatment of P. aeruginosa lung infections in cystic fibrosis patients; AmpliPhage-002 for the treatment of S. aureus infections, including methicillin-resistant S. aureus; and AmpliPhage-004 for the treatment of C. difficile infections. It has a collaboration agreement with Intrexon Corporation to utilize synthetic biology platform for the identification, development, and production of bacteriophage-containing human therapeutics. The company was formerly known as Targeted Genetics Corporation and changed its name to AmpliPhi Biosciences Corporation in February 2011. AmpliPhi Biosciences Corporation was founded in 1989 and is headquartered in Glen Allen, Virginia.

9 Employees
Last Reported Date: 09/12/14
Founded in 1989

ampliphi biosciences corp (APHB) Top Compensated Officers

Chief Scientific Officer
Total Annual Compensation: $225.5K
Compensation as of Fiscal Year 2013.

ampliphi biosciences corp (APHB) Key Developments

AmpliPhi Biosciences Corporation Announces Executive Changes

AmpliPhi BioSciences Corporation announced that Philip J. Young has stepped down from his role as President and CEO. Mr. Young's resignation was by mutual agreement with AmpliPhi's Board of Directors with his departure from the company being effective September 15, 2014. The company also announced that AmpliPhi's Chairman, Jeremy Curnock Cook, will serve as Interim CEO and Wendy Johnson, a member of AmpliPhi's Board or Directors, will serve as Interim COO, overseeing the company's operations until a new CEO is appointed. Mr. Cook was responsible for identifying and managing the acquisition of the AmpliPhi phage technology into the company and has been instrumental in refining the therapeutic phage platform concept over the past five years as the company's Chairman.

AmpliPhi Biosciences Corporation announced delayed 10-Q filing

On 08/15/2014, AmpliPhi Biosciences Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

AmpliPhi Biosciences Corporation Appoints David Bosher as Interim Chief Financial Officer

On June 30, 2014, AmpliPhi Biosciences Corporation appointed David Bosher to serve as the company’s interim Chief Financial Officer. Since October 1, 2013, Mr. Bosher is serving as Managing Director for Fahrenheit Advisors. His work experience also includes having served as Director of Corporate Accounting at a major publicly traded pharmaceutical firm and as senior audit professional with a regional public accounting firm.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
APHB:US $0.17 USD -0.0125

APHB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for APHB.
View Industry Companies

Industry Analysis


Industry Average

Valuation APHB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 112.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMPLIPHI BIOSCIENCES CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at